Skip to main content
NVDA-2.45%AAPL+2.59%GOOGL+0.45%MSFT-0.04%AMZN-0.07%TSM-1.20%SPCX+1.15%AVGO-0.54%META-0.77%TSLA-0.64%SKHY-3.86%MU-4.52%BRK-B-0.16%LLY+0.40%JPM-0.53%WMT+0.12%AMD-2.80%V-0.31%XOM+0.85%ASMLa-1.66%JNJ+0.01%INTC-4.89%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.73%ABBV+0.69%BAC-0.47%CSCO-1.32%CVX-0.09%COST-0.15%KO+0.66%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.47%UNH-0.55%HSBA.L-1.30%DELL-3.92%PG+0.14%MS-0.99%GE-0.74%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.02%HD-1.60%0939.HK+1.66%GS-1.00%NZDJPY-2.57%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.38%GBPNZD+1.37%USDJPY-1.22%GBPJPY-1.21%EURJPY-1.20%CADJPY-1.15%NZDCHF-1.03%USDZAR+1.02%USDSEK+0.88%EURZAR+0.87%USDNOK+0.86%AUDNZD+0.80%GBPZAR+0.79%EURSEK+0.73%EURNOK+0.72%AUDCAD-0.68%AUDDKK-0.64%EURAUD+0.61%USDTHB+0.60%AUDUSD-0.58%GBPAUD+0.57%CHFSEK+0.57%CHFNOK+0.55%AUDSGD-0.53%USDMXN+0.44%CADCHF+0.42%USDPLN+0.41%GBPTRY+0.41%NZDSGD-0.40%EURCHF+0.38%USDCHF+0.37%GBPCHF+0.35%NOKJPY-0.34%GBPHKD+0.32%GBPMXN-0.28%SGDJPY+0.26%EURPLN+0.26%USDSGD+0.25%NZDMXN-0.23%AUDCHF-0.22%USDILS+0.16%EURHKD-0.16%USDDKK+0.15%USDTRY+0.11%PLNJPY+0.11%EURSGD+0.11%USDCNH+0.10%EURCZK-0.09%GBPCAD-0.08%AUDNOK+0.07%USDCAD-0.06%CHFSGD-0.06%EURCAD-0.05%USDCOP-0.04%EURGBP+0.03%EURCNH-0.03%GBPSGD+0.02%EURUSD+0.02%USDHKD+0.01%GBPUSD+0.01%EURDKK0.00%XPTUSD-5.82%UKOIL+5.74%USOIL+5.51%GAGUSD-5.16%XAGUSD-5.16%HG1-4.93%GAUUSD-1.33%XAUUSD-1.33%XNGUSD+1.26%S1+0.97%COTTON+0.95%W1+0.92%BTCUSD-1.60%ETHUSD-0.41%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.06%TRXUSDT+0.18%ZECUSDT-8.90%DOGEUSD-3.20%XMRUSDT-0.36%LINKUSD-1.58%XLMUSD-1.64%BCHUSDT-10.50%LTCUSD-2.09%UNIUSD-2.09%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.44%TAOUSDT-5.35%AAVEUSD-2.69%DOTUSDT-2.18%ICPUSDT-2.12%ONDOUSDT-3.45%WLDUSDT-3.15%ATOMUSDT-3.73%ARBUSDT-0.36%JUPUSDT-4.67%INJUSDT-3.45%STXUSDT-3.80%FETUSDT-3.74%TIAUSDT-1.39%PYTHUSDT-1.39%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.69%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.55%IOTAUSDT-4.04%AXSUSDT-2.68%FARTCOINUSDT-4.54%EOSUSDT-3.15%DYDXUSDT-2.64%ORDIUSDT-1.16%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.45%AAPL+2.59%GOOGL+0.45%MSFT-0.04%AMZN-0.07%TSM-1.20%SPCX+1.15%AVGO-0.54%META-0.77%TSLA-0.64%SKHY-3.86%MU-4.52%BRK-B-0.16%LLY+0.40%JPM-0.53%WMT+0.12%AMD-2.80%V-0.31%XOM+0.85%ASMLa-1.66%JNJ+0.01%INTC-4.89%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.73%ABBV+0.69%BAC-0.47%CSCO-1.32%CVX-0.09%COST-0.15%KO+0.66%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.47%UNH-0.55%HSBA.L-1.30%DELL-3.92%PG+0.14%MS-0.99%GE-0.74%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.02%HD-1.60%0939.HK+1.66%GS-1.00%NZDJPY-2.57%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.38%GBPNZD+1.37%USDJPY-1.22%GBPJPY-1.21%EURJPY-1.20%CADJPY-1.15%NZDCHF-1.03%USDZAR+1.02%USDSEK+0.88%EURZAR+0.87%USDNOK+0.86%AUDNZD+0.80%GBPZAR+0.79%EURSEK+0.73%EURNOK+0.72%AUDCAD-0.68%AUDDKK-0.64%EURAUD+0.61%USDTHB+0.60%AUDUSD-0.58%GBPAUD+0.57%CHFSEK+0.57%CHFNOK+0.55%AUDSGD-0.53%USDMXN+0.44%CADCHF+0.42%USDPLN+0.41%GBPTRY+0.41%NZDSGD-0.40%EURCHF+0.38%USDCHF+0.37%GBPCHF+0.35%NOKJPY-0.34%GBPHKD+0.32%GBPMXN-0.28%SGDJPY+0.26%EURPLN+0.26%USDSGD+0.25%NZDMXN-0.23%AUDCHF-0.22%USDILS+0.16%EURHKD-0.16%USDDKK+0.15%USDTRY+0.11%PLNJPY+0.11%EURSGD+0.11%USDCNH+0.10%EURCZK-0.09%GBPCAD-0.08%AUDNOK+0.07%USDCAD-0.06%CHFSGD-0.06%EURCAD-0.05%USDCOP-0.04%EURGBP+0.03%EURCNH-0.03%GBPSGD+0.02%EURUSD+0.02%USDHKD+0.01%GBPUSD+0.01%EURDKK0.00%XPTUSD-5.82%UKOIL+5.74%USOIL+5.51%GAGUSD-5.16%XAGUSD-5.16%HG1-4.93%GAUUSD-1.33%XAUUSD-1.33%XNGUSD+1.26%S1+0.97%COTTON+0.95%W1+0.92%BTCUSD-1.60%ETHUSD-0.41%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.06%TRXUSDT+0.18%ZECUSDT-8.90%DOGEUSD-3.20%XMRUSDT-0.36%LINKUSD-1.58%XLMUSD-1.64%BCHUSDT-10.50%LTCUSD-2.09%UNIUSD-2.09%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.44%TAOUSDT-5.35%AAVEUSD-2.69%DOTUSDT-2.18%ICPUSDT-2.12%ONDOUSDT-3.45%WLDUSDT-3.15%ATOMUSDT-3.73%ARBUSDT-0.36%JUPUSDT-4.67%INJUSDT-3.45%STXUSDT-3.80%FETUSDT-3.74%TIAUSDT-1.39%PYTHUSDT-1.39%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.69%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.55%IOTAUSDT-4.04%AXSUSDT-2.68%FARTCOINUSDT-4.54%EOSUSDT-3.15%DYDXUSDT-2.64%ORDIUSDT-1.16%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
LT

LENZ Therapeutics, Inc. (LENZ)

NASDAQ • Healthcare

$4.91
-$0.41 (-7.9%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$5.31
Previous Close$4.91
Day Range$4.89 - $5.41
Avg. Volume (3M)746.3K
Market Cap$149.2M
52 Week Range
$4.54$50.4
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$5.4M100%
Gross Profitminus cost of goods$5.2M95%

Fundamentals & Financials

Revenue (TTM)
$21.4M
Net Income (TTM)
-$126M
EPS (TTM)
-$4.09
ROA (TTM)
-53.26%
Current Ratio
13.55
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-27.5%Q1 2026-$1.16
-20.0%Q2 2026-$1.32
+2.9%Q3 2026-$1.02
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc. develops eye-care therapies in the healthcare sector, operating as a biotechnology company focused on treatments that improve vision. Listed on the NASDAQ as LENZ, it advances and seeks to commercialize prescription products for presbyopia, and generated $19.1 million of revenue in FY2025.

Name
LENZ Therapeutics, Inc.
CEO
Evert Schimmelpennink
Website
www.lenz-tx.com
Industry
Healthcare
Employees
152

Today's Snapshot

AI-generated

So far today, LENZ is trading 3% lower at 4.76, while its sector was flat. LENZ remains within 5% of its 52-week low of 4.54. Pomerantz, an investor law firm, is investigating LENZ Therapeutics over investor claims.

Trading Volume

Below 10d avg (637.2K)

267.5K

vs S&P 500 Today

Underperforming Market

-2.49%

Updated: September 10, 2026 at 17:03 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
LENZ shows a neutral technical profile as momentum indicators are mixed and trend strength is weak. The RSI sits in the low-40s while the MACD level provides a modest buy signal, yet price is trading below short- and longer-term moving averages including the 200-day, which keeps broader bias cautious. ADX near 19 indicates a lack of a decisive trend, and ATR points to notable intraday range relative to price. On-balance volume reads as accumulation even though the classic pivot sits above the market. Technical takeaway: neutral overall, with mixed momentum and volume offsetting the downside pressure from moving averages.
All signals
  • EMA (5 indicators)$5.17 - $13.55
    Sell
  • RSI (14)42.23
    Neutral
  • Stochastic %K (14, 3, 3)31.82
    Neutral
  • MACD Level (12, 26)0.00
    Buy

Peers & Related Assets

MRVIMaravai LifeSciences Holdings, Inc.
$6.95-3.3%
TYRATyra Biosciences, Inc.
$22.01-17.7%
SVRASavara Inc.
$5.42-2.0%
ABUSArbutus Biopharma Corp
$5.17-0.2%
GERNGeron Corporation
$1.4-7.3%
PRMEPrime Medicine, Inc.
$3.47-2.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.